| Financial Year |
March 31 2022 |
| Monetary Funds |
522,887,843.86 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
2,587,361.27 |
| Accounts Receivable |
1,655,008,467.19 |
| Advances to Suppliers |
132,549,537.15 |
| Other Receivables |
18,426,871.38 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,190,995,841.55 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
55,731,511.54 |
| Total Current Assets |
4,317,423,736.69 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
107,719,260.05 |
| Investment Properties |
-- |
| Fixed Assetes |
2,802,366,527.46 |
| Under-construction Projects |
213,243,295.73 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
231,794,134.77 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
16,552,479.54 |
| Deferred Income Tax Assets |
56,769,503.90 |
| Other Non-Current Assets |
17,938,741.75 |
| Sub-Total of Non-Current Assets |
3,465,643,863.26 |
| Total Assets |
7,783,067,599.95 |
| Short-Term Loans |
1,688,007,755.89 |
| Trading Financial liabilities |
-- |
| Notes Payable |
944,261,201.39 |
| Accounts Payable |
652,704,360.20 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
7,227,473.51 |
| Taxes Payable |
30,475,617.93 |
| Interest Payable |
-- |
| Dividend Payable |
378,363.00 |
| Other payables |
160,861,833.26 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
401,360,261.44 |
| Other Current Liabilities |
13,714,122.92 |
| Sub-Total of Current Liabilities |
3,988,528,100.09 |
| Long-term Loans |
300,348,333.33 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
150,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
399,060,438.27 |
| Total Liabilities |
4,387,588,538.36 |
| Paid-In Capital(Or Share Stock) |
748,119,596.00 |
| Capital Surplus |
1,477,107,838.76 |
| Surplus Reserve |
168,299,788.05 |
| LESS:Treasury Stock |
52,179,482.25 |
| Undistributed Profits |
886,583,196.83 |
| Minority Stockholder's Interest |
143,877,360.78 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,251,601,700.81 |
| Owner's Equity（Stockholder's Equity） |
3,395,479,061.59 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,783,067,599.95 |
